XELODA Safety Questions, XELODA Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about XELODA. Our extensive database of XELODA adverse events and XELODA warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about XELODA

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




XELODA Safety Reports

Total XELODA reports: 523.
XELODA FDA safety alerts: 2001 .
Reported deaths: 156    Reported hospitalizations: 225.
Take XELODA Side Effects Survey or Share Your XELODA Story. XELODA Usage.

Showing 1-75 of 523 Next >

Consumer or non-health professional from SWITZERLAND reported XELODA problem on Mar 09, 2007. Female patient, 59 years of age, was diagnosed with breast cancer female, metastases to bone and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: osteonecrosis. XELODA dosage: unknown. During the same period patient was treated with ZOMETA. Patient recovered.

XELODA problem was reported by a Pharmacist from SOUTH AFRICA on Mar 09, 2007. Male patient, 73 years of age, was diagnosed with hypotension and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: balanitis, palmar-plantar erythrodysaesthesia syndrome. XELODA dosage: PATIENT RECEIVED 1500 MG IN THE MORNING AND 1000 MG IN THE EVENING.. During the same period patient was treated with EFFORTIL. Patient recovered.

Consumer or non-health professional from SWITZERLAND reported XELODA problem on Mar 12, 2007. Male patient, 46 years of age, was diagnosed with prophylaxis and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: intestinal ischaemia, large intestine perforation. XELODA dosage: unknown. During the same period patient was treated with ANZEMET, TAXOTERE, MEPHAMESONE, CISPLATIN, EMEND. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from UNITED STATES on Mar 12, 2007. Male patient, 58 years of age, weighting 170.0 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome, vasculitis. XELODA dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CHINA reported XELODA problem on Mar 09, 2007. Male patient, 69 years of age, was diagnosed with small intestine carcinoma and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cerebral infarction. XELODA dosage: unknown. Patient recovered.

XELODA problem was reported by a Pharmacist from UNITED KINGDOM on Mar 14, 2007. Male patient, 72 years of age, weighting 136.7 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, renal failure, vomiting. XELODA dosage: unknown. Patient was hospitalized. Patient died.

Physician from UNITED STATES reported XELODA problem on Mar 12, 2007. Male patient, 90 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: colon cancer metastatic, dysarthria, fall, gait disturbance, somnolence, transient ischaemic attack. XELODA dosage: unknown. Patient died on 03/08/2007.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 09, 2007. Male patient, weighting 80.03 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: colon cancer metastatic, coma, haemorrhage, overdose, rash macular. XELODA dosage: unknown. During the same period patient was treated with ASPIRIN. Patient was hospitalized. Patient died on 07/17/2005.

Physician from FRANCE reported XELODA problem on Mar 15, 2007. Female patient, 60 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, renal failure, vomiting. XELODA dosage: THE DOSE WAS REPORTED AS ^1250 MG/M2 TWICE^. THE FIRST CYCLE HAD A WEEK OF DISCONTINUATION FOLLOWIN+. During the same period patient was treated with TAMOXIFEN CITRATE, TAXOTERE. Patient died.

XELODA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 16, 2007. Male patient, 36 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: chills, hypothermia, neutropenia. XELODA dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient recovered.

Physician from ITALY reported XELODA problem on Mar 22, 2007. Female patient, 71 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. XELODA dosage: STRENGHT REPORTED AS UNK MG.. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from NEW ZEALAND on Mar 21, 2007. Female patient, 52 years of age, weighting 175.0 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock, cardiotoxicity. XELODA dosage: unknown. Patient recovered.

Physician from GERMANY reported XELODA problem on Mar 22, 2007. Female patient, 79 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: anorexia, ascites, depression, disease progression, gastric polyps, hyperthyroidism, hypoglycaemia, insulinoma. XELODA dosage: unknown. During the same period patient was treated with HERCEPTIN, NAVELBINE, AROMASIN, TAMOXIFEN CITRATE, TAXOL, BIPHOSPHONATE, AREDIA, ARIMIDEX. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from UNITED STATES on Apr 02, 2007. Female patient, weighting 157.0 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: anorexia, condition aggravated, nausea, parkinson's disease. XELODA dosage: 2000MG BID PO. During the same period patient was treated with LIPITOR, LEVOXYL, ATIVAN, ZOFRAN, PROCHLORPERAZINE. Patient recovered.

Consumer or non-health professional from CANADA reported XELODA problem on Mar 26, 2007. Female patient, 58 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: insomnia, oedema peripheral, pulmonary oedema. XELODA dosage: unknown. Patient was hospitalized. Patient died on 11/09/2006.

XELODA problem was reported by a Physician from FRANCE on Mar 27, 2007. Male patient, 68 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: visual disturbance. XELODA dosage: unknown. Patient recovered.

Physician from JAPAN reported XELODA problem on Mar 28, 2007. Female patient, 50 years of age, was diagnosed with breast cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: inappropriate antidiuretic hormone secretion. XELODA dosage: unknown. Patient died.

XELODA problem was reported by a Physician from GERMANY on Mar 30, 2007. Male patient, weighting 136.7 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, inflammation, mucosal inflammation, pyrexia, shock. XELODA dosage: 2X1000 MG/M2 FROM DAYS 1 TO 14 OF A TWO WEEK CYCLE. (CYCLE 1).. During the same period patient was treated with OXALIPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.

Physician from RUSSIAN FEDERATION reported XELODA problem on Mar 30, 2007. Male patient, 65 years of age, was diagnosed with colon cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: angina pectoris, intestinal obstruction. XELODA dosage: unknown. Patient died.

XELODA problem was reported by a Physician from ITALY on Mar 30, 2007. Female patient, 71 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, diarrhoea. XELODA dosage: STRENGHT REPORTED AS UNK MG.. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XELODA problem on Mar 29, 2007. Male patient, 65 years of age, weighting 159.0 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: asthenia, cardiac arrest, diarrhoea, hepatitis, intestinal ischaemia, large intestine perforation, mucosal inflammation, rhabdomyolysis, sepsis. XELODA dosage: unknown. During the same period patient was treated with AVASTIN, OXALIPLATIN, ZOCOR, LEVOFLOXACIN, FLAGYL. Patient was hospitalized. Patient died on 01/02/2007.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2007. Female patient, 84 years of age, weighting 110.0 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, dry skin, dyspnoea exertional, myocardial infarction, pain, palmar-plantar erythrodysaesthesia syndrome, pruritus. XELODA dosage: THE PATIENT WAS GIVEN A PRESCRIPTION FOR XELODA 1500 MG TWICE DAILY FOR 14 DAYS. SHE COMPLETED 4 C+. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XELODA problem on Apr 02, 2007. Male patient, 65 years of age, weighting 159.0 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: asthenia, cardiac arrest, diarrhoea, hepatitis, intestinal ischaemia, large intestine perforation, mucosal inflammation, rhabdomyolysis, shock. XELODA dosage: unknown. During the same period patient was treated with AVASTIN, OXALIPLATIN, ZOCOR, LEVOFLOXACIN, FLAGYL. Patient was hospitalized. Patient died on 01/02/2007.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, weighting 114.6 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: asthenia, melaena. XELODA dosage: 54000 MG. During the same period patient was treated with CAMPTOSAR, ASPIRIN, FISH OIL, LASIX, LIPITOR, VITAMIN WITH IRON, TOPROL. Patient was hospitalized. Patient recovered.

Pharmacist from FRANCE reported XELODA problem on Apr 05, 2007. Female patient, 56 years of age, was diagnosed with breast cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: polydipsia. XELODA dosage: unknown. Patient recovered.

XELODA problem was reported by a Physician from NEW ZEALAND on Apr 05, 2007. Female patient was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: portal vein thrombosis. XELODA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from POLAND reported XELODA problem on Apr 03, 2007. Female patient, 58 years of age, was diagnosed with breast cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, enteritis, multi-organ failure, oesophagitis, palmar-plantar erythrodysaesthesia syndrome, pharyngeal inflammation. XELODA dosage: unknown. Patient was hospitalized. Patient died.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Male patient, 85 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, cardiac failure congestive, chest pain, coronary artery disease. XELODA dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported XELODA problem on Apr 13, 2007. Male patient was diagnosed with neoplasm malignant and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. XELODA dosage: 1500MG 2X/DAY X 14 DAYS PO. Patient recovered.

XELODA problem was reported by a Pharmacist from UNITED STATES on Apr 13, 2007. Female patient was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea. XELODA dosage: 500MG 2 - BID PO MID -JAN. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XELODA problem on Apr 11, 2007. Male patient, weighting 170.0 lb, was diagnosed with colon cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome, vasculitis. XELODA dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from FRANCE on Mar 27, 2007. Male patient, 68 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: visual disturbance. XELODA dosage: unknown. Patient recovered.

Physician from SWEDEN reported XELODA problem on Apr 12, 2007. Male patient, 51 years of age, weighting 169.8 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cardiac failure. XELODA dosage: unknown. During the same period patient was treated with ERLOTINIB, GEMCITABINE, OXALIPLATIN, NOVOMIX, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE. Patient died on 12/24/2006.

XELODA problem was reported by a Consumer or non-health professional from SPAIN on Apr 12, 2007. Male patient, 60 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: oesophagitis, vomiting. XELODA dosage: unknown. During the same period patient was treated with GEMZAR, CAPOTEN, COLCHIMAX, OMEPRAZOLE, DIPYRONE, EMPORTAL, ONDANSETRON. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported XELODA problem on Apr 13, 2007. Female patient, 34 years of age, weighting 163.1 lb, was diagnosed with breast cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: chest discomfort, hyperventilation, pharyngeal mass. XELODA dosage: unknown. Patient recovered.

XELODA problem was reported by a Physician from CHILE on Apr 11, 2007. Female patient, 65 years of age, weighting 123.5 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: asthenia, cardiogenic shock, dyspnoea, embolism. XELODA dosage: unknown. Patient died on 03/30/2007.

Consumer or non-health professional from FRANCE reported XELODA problem on Apr 13, 2007. Female patient, 71 years of age, was diagnosed with rectal cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hypokalaemia, hypoproteinaemia, vomiting, weight decreased. XELODA dosage: unknown. During the same period patient was treated with ELOXATIN, FOLFOX. Patient recovered.

XELODA problem was reported by a Physician from FINLAND on Apr 13, 2007. Female patient, 76 years of age, weighting 176.4 lb, was diagnosed with rheumatoid arthritis and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: bacterial sepsis, c-reactive protein increased, chest pain, coronary artery thrombosis, deep vein thrombosis, depressed level of consciousness, diarrhoea, haematochezia, leukopenia. XELODA dosage: unknown. During the same period patient was treated with TREXAN, PREDNISONE, OXIKLORIN, LIPCUT, NEXIUM, KALCIPOS, FOLVITE. Patient was hospitalized. Patient died on 12/01/2006.

Consumer or non-health professional from UNITED STATES reported XELODA problem on Apr 23, 2007. Female patient, weighting 114.6 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: adverse event, asthenia, fatigue, melaena. XELODA dosage: 54000 MG. During the same period patient was treated with CAMPTOSAR, ASPIRIN, FISH OIL, LASIX, LIPITOR, VITAMIN WITH IRON, TOPROL. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from UNITED STATES on Apr 16, 2007. Female patient, 62 years of age, weighting 82.89 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, diarrhoea. XELODA dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported XELODA problem on Apr 19, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: supraventricular tachycardia. XELODA dosage: unknown. During the same period patient was treated with ELOXATIN, AVASTIN. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from RUSSIAN FEDERATION on Apr 13, 2007. Male patient, 65 years of age, was diagnosed with colon cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: angina pectoris, intestinal obstruction, peritonitis. XELODA dosage: unknown. Patient died on 02/12/2007.

Consumer or non-health professional from FRANCE reported XELODA problem on Apr 17, 2007. Female patient, 79 years of age, weighting 94.80 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: glossitis. XELODA dosage: unknown. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from SWITZERLAND on Apr 18, 2007. Female patient, 77 years of age, was diagnosed with diabetes mellitus and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: prothrombin time prolonged, subdural haematoma. XELODA dosage: unknown. During the same period patient was treated with ASPIRIN, AMARYL, GLUCOPHAGE, COAPROVEL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XELODA problem on Apr 18, 2007. Female patient was diagnosed with colorectal cancer, hepatic neoplasm malignant and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: disease progression. XELODA dosage: unknown. During the same period patient was treated with ELOXATIN, AVASTIN. Patient died.

XELODA problem was reported by a Consumer or non-health professional from FRANCE on Apr 16, 2007. Male patient, 69 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: facial palsy. XELODA dosage: unknown. During the same period patient was treated with CISPLATIN, FARMORUBICINE. Patient was hospitalized. Patient recovered.

Physician from CHILE reported XELODA problem on Apr 20, 2007. Female patient, 65 years of age, weighting 123.5 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: asthenia, cardiogenic shock, dyspnoea, embolism, pleural effusion. XELODA dosage: unknown. Patient died on 03/30/2007.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient, 69 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: thrombosis. XELODA dosage: unknown. During the same period patient was treated with LENTINAN, GREEN TEA. Patient recovered.

Physician from UNITED STATES reported XELODA problem on Apr 16, 2007. Female patient, 79 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: optic neuritis. XELODA dosage: unknown. During the same period patient was treated with COMPAZINE. Patient recovered.

XELODA problem was reported by a Health Professional from UNITED STATES on Apr 19, 2007. Male patient, 89 years of age, weighting 140.9 lb, was diagnosed with idiopathic thrombocytopenic purpura and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, eating disorder, gastritis, idiopathic thrombocytopenic purpura, influenza, oesophagitis, palmar-plantar erythrodysaesthesia syndrome. XELODA dosage: unknown. During the same period patient was treated with PREDNISONE. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported XELODA problem on Apr 23, 2007. Male patient, 68 years of age, weighting 136.7 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. XELODA dosage: unknown. Patient recovered.

XELODA problem was reported by a Health Professional from UNITED STATES on Apr 24, 2007. Male patient was diagnosed with colorectal cancer metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: supraventricular tachycardia. XELODA dosage: unknown. During the same period patient was treated with ELOXATIN, AVASTIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED KINGDOM reported XELODA problem on Apr 25, 2007. Male patient, 72 years of age, weighting 136.7 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, renal failure, vomiting. XELODA dosage: unknown. During the same period patient was treated with WARFARIN, ATORVASTATIN CALCIUM, TAMSULOSIN, AMIODARONE, FRUSEMIDE, GLICLAZIDE, OMEPRAZOLE. Patient was hospitalized. Patient died.

XELODA problem was reported by a Physician from IRELAND on Apr 23, 2007. Female patient, 77 years of age, weighting 125.7 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, neutropenia. XELODA dosage: DOSE: 1000MG/M2.. During the same period patient was treated with NEORECORMON, TENORMIN, LIPITOR, LASIX, SOLPADEINE. Patient was hospitalized. Patient died on 04/04/2007.

Health Professional from UNITED STATES reported XELODA problem on Apr 25, 2007. Female patient, 48 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, gastrointestinal disorder, hepatic enzyme increased, pleural effusion, urinary tract infection. XELODA dosage: unknown. During the same period patient was treated with TAXOTERE. Patient died on 04/16/2007.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 24, 2007. Male patient, 81 years of age, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, diarrhoea, pericardial effusion, pulmonary oedema. XELODA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XELODA problem on May 01, 2007. Female patient, 35 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: aggression, convulsion, loss of consciousness. XELODA dosage: unknown. Patient recovered.

XELODA problem was reported by a Consumer or non-health professional from GERMANY on May 04, 2007. Female patient, 59 years of age, was diagnosed with thrombosis prophylaxis and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: bundle branch block left, cardiac failure, mitral valve incompetence, myocardial infarction, pancytopenia, pulmonary embolism, tricuspid valve incompetence. XELODA dosage: unknown. During the same period patient was treated with MARCUMAR. Patient was hospitalized. Patient recovered.

Physician from JORDAN reported XELODA problem on May 08, 2007. Male patient, 53 years of age, weighting 147.7 lb, was diagnosed with diabetes mellitus and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: mouth ulceration, mucosal inflammation, palmar-plantar erythrodysaesthesia syndrome, pigmentation disorder. XELODA dosage: unknown. During the same period patient was treated with INSULIN. Patient recovered.

XELODA problem was reported by a Physician from EGYPT on May 08, 2007. Female patient, 55 years of age, was diagnosed with colorectal cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, iliac artery thrombosis, palmar-plantar erythrodysaesthesia syndrome. XELODA dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient died on 05/04/2007.

Physician from AUSTRALIA reported XELODA problem on May 09, 2007. Male patient, 72 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, intestinal obstruction, nausea. XELODA dosage: 2500 MG/M2/DAY DAYS 1-14 EVERY 3 WEEKS TOTAL DAILY DOSING AMOUNT (2500 MG/M2) DIVIDED INTO TWO DAIL+. During the same period patient was treated with BEVACIZUMAB, MITOMYCIN. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Health Professional from SPAIN on May 11, 2007. Female patient, 51 years of age, weighting 145.5 lb, was diagnosed with candidiasis, epilepsy and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, granulocytopenia, mucosal inflammation, neutropenia. XELODA dosage: unknown. During the same period patient was treated with LOITIN, DURAGESIC, NEOSIDANTOINA, NEURONTIN, PANTECTA. Patient was hospitalized. Patient died on 03/05/2007.

Health Professional from SPAIN reported XELODA problem on May 11, 2007. Female patient, 56 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: enanthema, genital rash, hyperaesthesia. XELODA dosage: unknown. Patient recovered.

XELODA problem was reported by a Consumer or non-health professional from UNITED STATES on May 11, 2007. Female patient, 75 years of age, was diagnosed with metastases to central nervous system, breast cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: fungaemia, fungal infection, melaena, vomiting. XELODA dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XELODA problem on May 15, 2007. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with rectal cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: impaired healing. XELODA dosage: unknown. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Health Professional from UNITED STATES on May 17, 2007. Female patient was diagnosed with breast cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: brain neoplasm. XELODA dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XELODA problem on May 24, 2007. Female patient, weighting 126.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: anorexia, electrocardiogram st-t segment depression, fatigue, infusion related reaction, nausea, no therapeutic response, temperature intolerance, vomiting. XELODA dosage: 1500MG BIDX14DAYS, 7DOFF ORALLY. During the same period patient was treated with PROTONIX, ATIVAN, COMPAZINE, ZOFRAN. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from POLAND on May 15, 2007. Male patient, 78 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, gastrointestinal mucosal disorder, palmar-plantar erythrodysaesthesia syndrome. XELODA dosage: unknown. Patient was hospitalized. Patient died on 05/14/2007.

Physician from JORDAN reported XELODA problem on May 22, 2007. Male patient, 53 years of age, weighting 147.7 lb, was diagnosed with diabetes mellitus and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: mouth ulceration, mucosal inflammation, palmar-plantar erythrodysaesthesia syndrome, pigmentation disorder. XELODA dosage: unknown. During the same period patient was treated with INSULIN. Patient was hospitalized and became disabled. Patient recovered.

XELODA problem was reported by a Physician from UNITED STATES on May 22, 2007. Female patient, 62 years of age, weighting 82.89 lb, was diagnosed with colon cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, diarrhoea. XELODA dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from POLAND reported XELODA problem on May 23, 2007. Female patient, 58 years of age, was diagnosed with breast cancer stage iv and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, enteritis, multi-organ failure, oesophagitis, palmar-plantar erythrodysaesthesia syndrome, pharyngeal inflammation. XELODA dosage: unknown. Patient was hospitalized. Patient died.

XELODA problem was reported by a Health Professional from UNITED KINGDOM on May 22, 2007. Female patient, 61 years of age, weighting 138.9 lb, was diagnosed with breast cancer, bone pain and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: depression, palmar-plantar erythrodysaesthesia syndrome, suicidal ideation. XELODA dosage: unknown. During the same period patient was treated with NAPROXEN. Patient recovered.

Health Professional from UNITED STATES reported XELODA problem on May 22, 2007. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with rectal cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: impaired healing. XELODA dosage: FREQUENCY REPORTED AS BID/D1-14/Q3W. DOSE: 750MG/M2 TAKEN TWICE A DAY EVERY 14 DAYS. During the same period patient was treated with BEVACIZUMAB, OXALIPLATIN. Patient was hospitalized. Patient recovered.

XELODA problem was reported by a Physician from GERMANY on May 21, 2007. Female patient, 79 years of age, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: disease progression, hyperthyroidism, insulinoma, spleen scan abnormal, ventricular extrasystoles. XELODA dosage: unknown. During the same period patient was treated with HERCEPTIN, NAVELBINE, AROMASIN, TAMOXIFEN, TAXOL, BIPHOSPHONATE, AREDIA, ARIMIDEX. Patient was hospitalized. Patient recovered.

Physician from EGYPT reported XELODA problem on May 24, 2007. Female patient, 55 years of age, was diagnosed with colorectal cancer and was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, palmar-plantar erythrodysaesthesia syndrome, peripheral ischaemia. XELODA dosage: unknown. During the same period patient was treated with OXALIPLATIN. Patient was hospitalized. Patient died on 05/04/2007.

Showing 1-75 of 523 Next >

Ask Our Patient Community about XELODA

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)